跳至主要内容
临床试验/NCT03044093
NCT03044093Unknown4 期

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion

Rambam Health Care Campus1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年1月最近更新:
适应症
干预措施

试验速览

阶段
4 期
入组人数
200
试验地点
1
主要终点
Reduction in Hospital Stay Duration

研究概览

简要总结

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion - a Double Blinded Randomized Controlled Trial

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • no allergy known to these drugs
  • second trimester abortion

排除标准

  • hematology diseases
  • clotting factor deficiency

研究组 & 干预措施

MISOPROSTOL alone

Active Comparator

the common practice currently in our medical center for second trimester medical abortion/ Placebo

干预措施: Placebo (Drug)

MISOPROSTOL alone

Active Comparator

the common practice currently in our medical center for second trimester medical abortion/ Placebo

干预措施: Misoprostol (Drug)

Mifepristone and Misoprostol

Experimental

in addition to the common practice currently in our medical center for second trimester medical abortion we will add Mifepristone before administering Misoprostol.

Mifepristone

干预措施: Mifepristone (Drug)

Mifepristone and Misoprostol

Experimental

in addition to the common practice currently in our medical center for second trimester medical abortion we will add Mifepristone before administering Misoprostol.

Mifepristone

干预措施: Misoprostol (Drug)

结局指标

主要结局

Reduction in Hospital Stay Duration

时间窗: Up to 24 months

number of days of hospital stay

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验